Market›Health Care›Biotechnology›Biotechnology
ZENAS BIOPHARMA INC Equity

ZBIO

$18.19Sep 13, 2024 – Apr 24, 2026
Health CareBiotechnology$1.32B
MVM
+$26.2M
TD Variance
0.619

Every news event mapped to its market reaction — 76 events, 20 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-01-05-57.2%executiveSeeking AlphaZenas crashes as late-stage trial data for lead asset disappoint
2026-01-05-57.2%newsStocktwitsWhy Is ZBIO Stock Falling Pre-Market Today? - Stocktwits
2025-10-08+32.8%legalSeeking AlphaZenas BioPharma files automatic mixed securities shelf
2025-10-08+32.8%M&ASeeking AlphaZenas climbs on licensing deal with InnoCare
2026-01-10+22.9%newsQuiver QuantitativeInsider Stock Purchases: January 10, 2026 - Quiver Quantitative
2026-01-10+22.9%executiveQuiver QuantitativeZenas BioPharma Stock (ZBIO) Opinions on INDIGO Trial Results and CEO Investment | ZBIO Stock News - Quiver Quantitative
2026-01-09+19.7%executiveInvesting.comZenas Biopharma (ZBIO) CEO Moulder buys $1.63m in stock - Investing.com
2025-05-15+19.5%earningsSeeking AlphaZenas BioPharma, Inc. GAAP EPS of -$0.80, revenue of $10M
2026-03-27-15.7%legalMT NewswiresSector Update: Health Care Stocks Softer Late Afternoon
2026-03-27-15.7%newsMT NewswiresTop Midday Decliners
2026-03-27-15.7%legalMT NewswiresSector Update: Health Care Stocks Retreat Friday Afternoon
2026-03-27-15.7%legalMT NewswiresSector Update: Health Care Stocks Decline Premarket Friday
2026-03-27-15.7%newsMT NewswiresWall Street Set to Open Lower in Friday Trading; Investors Not Assuaged by US Deadline Extension for Iran to Open Strait of Hormuz
2026-03-27-15.7%newsMT NewswiresZenas BioPharma Prices $287.5 Million Convertible Notes, Equity Offerings
2026-03-27-15.7%newsSeeking AlphaZenas BioPharma prices $300M capital raise in dual offering
2026-03-27-15.7%newsMSNZenas BioPharma prices $300M capital raise in dual offering - MSN
2026-03-26-14.5%newsSeeking AlphaZenas BioPharma announces concurrent public offerings of convertible senior notes and common stock
2026-03-26-14.5%expansionStock TitanZenas seeks fresh cash for planned drug launch, Phase 3 studies - Stock Titan
2026-03-26-14.5%newsGlobeNewswireZenas BioPharma Announces Proposed Concurrent Public - GlobeNewswire
2026-03-26-14.5%expansionStock TitanBiotech Zenas raises $300M to back drug launch and trials - Stock Titan
2025-08-12+10.7%earningsSeeking AlphaZenas BioPharma reports Q2 results
2025-04-07-10.5%earningsSeeking AlphaZenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst
2025-04-07-10.5%executiveSeeking AlphaZenas BioPharma names Haley Laken as chief scientific officer
2024-10-08-10.2%newsSeeking AlphaZenas started at buy by four banks on lead drug potential
2025-12-03+10.0%newsYahoo FinanceMeridian Small Cap Growth Fund Trimmed Zenas BioPharma (ZBIO) Following Share Price Appreciation - Yahoo Finance
2024-11-12-9.9%earningsSeeking AlphaZenas BioPharma, Inc. GAAP EPS of -$5.02
2026-04-01+8.9%legalMT NewswiresZenas BioPharma Insider Bought Shares Worth $1,021,140, According to a Recent SEC Filing
2026-04-01+8.9%newsStock TitanFairmount fund adds 150,000 Zenas BioPharma (ZBIO) shares - Stock Titan
2026-04-02+8.8%newsInvesting.comLu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 - Investing.com
2026-04-02+8.8%newsStock TitanLeon Moulder boosts Zenas BioPharma (ZBIO) stake to 4.794% ownership - Stock Titan
2026-04-02+8.8%newsStock TitanZenas BioPharma (ZBIO) director-affiliated funds purchase 3,768 shares - Stock Titan
2025-12-15-8.7%analystSeeking AlphaZenas Prepares For INDIGO Phase 3 Readout - Reinstating Buy Rating
2025-12-15-8.7%analystSeeking AlphaZenas Prepares For INDIGO Phase 3 Readout—Reinstating Buy Rating (ZBIO) - Seeking Alpha
2026-04-08-8.5%executiveTipRanksInsiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
2026-02-04+8.3%executiveSeeking AlphaZenas Bio rises after over $1M stock purchase by CEO
2026-02-04+8.3%executiveSeeking AlphaZenas Bio rises after over $1M stock purchase by CEO - Seeking Alpha
2026-03-31+8.0%newsTipRanksZenas BioPharma Raises Capital via Notes and Equity Offering - TipRanks
2026-03-31+8.0%newsStock TitanZenas BioPharma (ZBIO) raises capital via $200M converts and equity sale - Stock Titan
2026-03-31+8.0%executiveInvesting.comZenas BioPharma (ZBIO) CEO Moulder buys shares worth $1.02 million - Investing.com
2026-03-31+8.0%newsStock TitanDirector-linked funds add 75K Zenas BioPharma (ZBIO) shares at $20 in offering - Stock Titan
2026-03-31+8.0%executiveStock Titan54K-share open-market buy by CEO-linked entities at Zenas BioPharma (ZBIO) - Stock Titan
2024-10-22+7.7%newsSeeking AlphaZenas Bio: Recent IPO With Late-Stage Candidate
2025-09-02+7.3%expansionSeeking AlphaZenas BioPharma and Royalty Pharma enter into Obexelimab funding agreement for $300M
2025-11-21+7.3%newsSeeking AlphaBest Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap
2026-01-16+6.9%newsStock TitanNew hire at Zenas BioPharma receives option on 100,000 company shares - Stock Titan
2025-07-11+6.4%newssimplywall.stHere's Why We're Watching Zenas BioPharma's (NASDAQ:ZBIO) Cash Burn Situation - simplywall.st
2025-10-21-6.3%newsSeeking AlphaZenas BioPharma files to sell 6.31M shares of common stock for holders
2025-10-09+5.6%analystSeeking AlphaZenas BioPharma rises after Wedbush raises price target
2025-10-09+5.6%M&ASeeking AlphaZenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare Deal
2026-04-20-5.5%newsXã Thanh HàIs Zenas BioPharma (ZBIO) stock priced efficiently (Weakens) 2026-04-20 - High Reward Trade - Xã Thanh Hà
2026-04-20-5.5%newsCổng thông tin điện tử tỉnh Lào CaiIs Zenas BioPharma (ZBIO) stock priced efficiently (Weakens) 2026-04-20 - Community Pattern Alerts - Cổng thông tin điện tử tỉnh Lào Cai
2026-04-17-5.0%newsGlobeNewswireZenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-04-17-5.0%earningsMarketBeatZenas BioPharma, Inc. (NASDAQ:ZBIO) Short Interest Up 21.4% in March - MarketBeat
2026-01-28+4.2%newsStock TitanZBIO (Nasdaq: ZBIO) updates Crown Helix resale registration - Stock Titan
2026-03-16-3.6%earningsSeeking AlphaZenas BioPharma, Inc. GAAP EPS of -$4.54 misses by $3.66
2026-03-16-3.6%executiveQuiver QuantitativeZenas BioPharma, Inc. ($ZBIO) Founder, CEO and COB 2025 Pay Revealed | ZBIO Stock News - Quiver Quantitative
2026-03-16-3.6%newsStock TitanNew Zenas BioPharma hires receive 235,700 options, 33,450 RSUs - Stock Titan
2026-04-05+3.3%newssimplywall.stAssessing Zenas BioPharma (ZBIO) Valuation After US$300 Million Equity And Convertible Notes Financing - simplywall.st
2026-04-03+3.3%newsSeeking AlphaZenas BioPharma's Key Milestones And Market Context: Holding Through The BLA
2025-10-10-3.2%M&AYahoo FinanceZenas BioPharma (ZBIO) Is Up 32.5% After Securing Global Rights to Orelabrutinib in MS Deal - Yahoo Finance
2026-02-28-3.1%newsYahoo FinanceZenas BioPharma, Inc. (ZBIO): A Bull Case Theory - Yahoo Finance
2026-02-20-3.0%newsStock TitanZenas BioPharma awards new hires 35,700 options, 53,625 RSUs - Stock Titan
2025-11-12+2.9%earningsSeeking AlphaZenas BioPharma, Inc. GAAP EPS of -$1.22
2025-11-12+2.9%legalTradingViewZenas BioPharma, Inc. SEC 10-Q Report - TradingView
2025-07-28+2.8%newsSeeking AlphaZenas Biopharma: A Risky Buy On Upcoming Data Readouts In IgG4, MS
2024-09-27-2.4%legalSeeking AlphaBiotech IPOs return as sector recovers after funding overhang
2025-10-12-1.7%M&Asimplywall.stZenas BioPharma Independent Director Acquires 447% More Stock - simplywall.st
2025-03-20+1.5%expansionSeeking AlphaZenas Bio rises as Wedbush launches with Outperform on lead asset
2026-01-06-0.9%newsSeeking AlphaZenas BioPharma, Inc. (ZBIO) Discusses Positive Phase 3 INDIGO Trial Results for Obexelimab in IgG4-Related Disease Transcript
2026-01-06-0.9%newsSeeking AlphaZenas: Maintaining 'Strong Buy' As Cross-Trial Comparison Of Obexelimab Should Not Be A Factor
2026-01-06-0.9%newsZacks Investment ResearchShould I buy Zenas BioPharma, Inc. (ZBIO) - Zacks Investment Research
2026-01-06-0.9%newsBenzingaJefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
2026-03-29+0.4%newsSimply Wall St.Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk
2024-09-13—newsSeeking AlphaBicara, MBX Bio lead gainers as biotech trio makes trading debut
2024-09-13—newsSeeking AlphaZenas BioPharma prices $225M IPO at $17 per share
2024-09-13—newsStock TitanLatest ZBIO News - Zenas BioPharma Announces Inducement Grants... - Stock Titan
tickerdossier.comtickerdossier.substack.com